WHO – Global license deal reached for ‘at home test’ free to poorer countries.

Spanish National Research Council (CSIC) a public research institute offering the technology as a global public good, is the first test licence signed non exclsively by the WHO’s Medicines Patent Pool (MPP)“The aim of the licence is to facilitate the rapid manufacture and commercialisation of CSIC’s COVID-19 serological test worldwide,” the WHO said.

“The licence will be royalty-free for low- and middle-income countries and will remain valid until the date the last patent expires,” it said.

WHO director-general Tedros Adhanom Ghebreyesus welcomed the deal which he hoped would inspire other developers to share tools against COVID-19 which has killed 5.4 million people since the virus emerged in central China in December 2019.

“This is the kind of open and transparent licence we need to move the needle on access during and after the pandemic,” he said.

via: Reuters